Biological Potential and Bioaccessibility of Encapsulated Curcumin into Cetyltrimethylammonium Bromide Modified Cellulose Nanocrystals
Pharmaceuticals · 17.12.2023 · 16 (12) · 1737
DOI: 10.3390/ph16121737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 17.12.2023. Verfasst von Francisca Casanova und 9 weiteren Autor:innen. Beteiligte Einrichtung: CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Bote…. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Fundação para a Ciência e Tecnologia, scientific collaboration under the FCT project.
Abstract (Originalsprache)
Curcumin is a natural phenolic compound with important biological functions. Despite its demonstrated efficacy in vitro, curcumin biological activities in vivo are dependent on its bioaccessibility and bioavailability, which have been highlighted as a crucial challenge. Cetyltrimethylammonium bromide-modified cellulose nanocrystals (CNC-CTAB) have been shown to be effective in curcumin encapsulation, as they have the potential to enhance biological outcomes. This study evaluated the biological effects of curcumin encapsulated within CNC-CTAB structures, namely its antioxidant, anti-inflammatory and antimicrobial properties, as well as the release profile under digestion conditions and intestinal permeability. Encapsulated curcumin demonstrated antioxidant and anti-inflammatory properties, effectively reducing reactive oxygen species and cytokine production by intestinal cells. The delivery system exhibited antimicrobial properties against Campylobacter jejuni bacteria, further suggesting its potential in mitigating intestinal inflammation. The system showed the ability to protect curcumin from degradation and facilitate its interaction with the intestinal epithelium, highlighting the potential of CNC-CTAB as carrier to enhance curcumin intestinal biological functions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.
ORCID-Profile: Alessandra B Ribeiro, Pedro M Castro, Eva Martins, Manuela E Pintado
Förderung
- European Regional Development Fund
- Fundação para a Ciência e Tecnologia
- scientific collaboration under the FCT project
Zitieren
APA
Casanova, F., Pereira, C. F., Ribeiro, A. B., Castro, P. M., Freixo, R., Martins, E., Tavares-Valente, D., Fernandes, J. C., Pintado, M. E., & Ramos, Ó. L. (2023). Biological Potential and Bioaccessibility of Encapsulated Curcumin into Cetyltrimethylammonium Bromide Modified Cellulose Nanocrystals. Pharmaceuticals, 16(12), 1737. https://doi.org/10.3390/ph16121737
Vancouver
Casanova F, Pereira CF, Ribeiro AB, Castro PM, Freixo R, Martins E, et al. Biological Potential and Bioaccessibility of Encapsulated Curcumin into Cetyltrimethylammonium Bromide Modified Cellulose Nanocrystals. Pharmaceuticals. 2023;16(12):1737. doi:10.3390/ph16121737
BibTeX
@article{Casanova2023,
author = {Casanova, Francisca and Pereira, Carla F and Ribeiro, Alessandra B and Castro, Pedro M and Freixo, Ricardo and Martins, Eva and Tavares-Valente, Diana and Fernandes, João C and Pintado, Manuela E and Ramos, Óscar L},
title = {Biological Potential and Bioaccessibility of Encapsulated Curcumin into Cetyltrimethylammonium Bromide Modified Cellulose Nanocrystals},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {12},
pages = {1737},
doi = {10.3390/ph16121737}
}
EUVIMED